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Abstract
Background: A prospective, randomized, placebo-controlled, blinded clinical study was conducted to determine
whether a single dose of midazolam affects the cardiovascular response to surgical manipulation of the ovaries
during elective ovariohysterectomy. Thirty-nine client-owned dogs undergoing elective ovariohysterectomy were
recruited. After scoring cage demeanour, dogs were premedicated with acepromazine (0.03 mg kg-1) and pethidine
(3 mg kg-1) intramuscularly into the quadriceps muscle and 20 min later sedation was scored. Anaesthesia was
induced with propofol intravenously (IV) to effect. The study treatment (group M: midazolam (0.25 mg kg-1); or
group P: placebo (Hartmann’s solution) (0.125ml kg-1)) was administered IV before the intra-operative manipulation of
the first ovary. Anaesthesia was maintained with isoflurane in oxygen. Morphine (0.3 mg kg-1 IV) was administered prior
to the start of surgery. The vaporizer setting was adjusted according to the depth of anaesthesia. If an end-tidal
isoflurane concentration (FE’Iso) above 1.6% was required additional analgesia was provided with fentanyl (2 μg kg-1).
Dogs received meloxicam (0.2 mg kg-1 IV) at the end of procedure. Heart rate, mean arterial blood pressure, respiratory
rate and end-tidal partial pressure of carbon dioxide as well as FE’Iso were recorded and analysed.
Results: A statistical significant difference between groups was detected in FE’Iso, with group M requiring a significantly
lower FE’Iso than group P (14.3%) after administration of midazolam. No differences between groups was shown for
percentage change in heart rate and mean arterial blood pressure, or end-tidal carbon dioxide and requirement for
mechanical ventilation, or rescue analgesia. There was no statistically significant difference in the incidence of
complications in group M and P. Group M received significantly more succinylated gelatin solution pre-administration of
midazolam than group P, but no differences in fluid administration post-administration of the study treatment
(midazolam/placebo) were detected. No statistical significant difference was demonstrated for the use of anticholinergic
agents, dobutamine or noradrenaline.
Conclusion: No significant effect on cardiovascular parameters could be observed with administration of midazolam, but
a modest (14.3%) isoflurane-sparing effect was detected.
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Background
Ovariohysterectomy of the bitch is a common surgical pro-
cedure performed in veterinary medicine [1–3] and it is
quite often the first surgery veterinary medicine students
and recent graduates will be asked to perform [1, 4].
The canine ovary is richly innervated by sensory, sym-
pathetic and parasympathetic nerve fibres, that travel
alongside the ovarian artery and vein inside the ovarian
pedicle [5–8]. Traction on the suspensory ligament and
clamping of the ovarian pedicle generate a particularly
painful stimulus during the ovariohysterectomy proced-
ure [9]. The mesovarial injection of local anaesthetic
resulted in a significantly lower pain response in cats,
horses and humans [8, 10, 11]. In contrast, mesovarial
injection of lidocaine in dogs undergoing ovariohyster-
ectomy did not decrease isoflurane requirements, nor
lessen the autonomic response to surgical manipulation
[9]. Other methods may have to be considered to
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attenuate the nociceptive response to the surgical
manipulation of the ovarian pedicle, and veterinarians
working in general practice have anecdotally suggested
that the administration of benzodiazepines may have
such an attenuating effect.
Intra-operative detection of pain relies on the observa-
tion and interpretation of autonomic changes, especially
cardiovascular and respiratory responses [12–14]. An-
aesthesia and analgesia are intrinsically linked and auto-
nomic parameters can both be an indicator of changes
in the nociception – anti-nociception balance and/or
changes in depth of anaesthesia [13, 14].
Midazolam is an imidazobenzdiazepine that acts as an
agonist on the GABAA receptor. Similar to other benzodi-
azepine agonists it induces anticonvulsant, anxiolytic,
sedative/hypnotic, amnesic and centrally mediated muscle
relaxant effects [15]. Systemically administered it is not
thought to be analgesic [16]. It was shown to cause min-
imal cardiovascular changes at clinically relevant doses
[17] but is associated with a dose-related centrally
mediated respiratory depression [18].
The primary objective of the study was to determine the
effect of midazolam on the cardiovascular response to the
surgical manipulation of the ovaries during elective
ovariohysterectomy. A secondary objective was to deter-
mine the effect of midazolam on the isoflurane concentra-
tion required to maintain a surgical plane of anaesthesia.
Our null hypothesis was that administration of a single
bolus of midazolam at a dose of 0.25 mg kg-1 would not
exert a significant effect on the cardiovascular parame-
ters heart rate (HR) and mean arterial blood pressure
(MAP) in healthy dogs undergoing elective ovariohyster-
ectomy at a tertiary referral university teaching hospital.
Our secondary null hypothesis was that the administra-
tion of midazolam would have no isoflurane-sparing
effect during surgical manipulation.
Methods
Animals
The conducted study was approved by the University
College Dublin (UCD) Office of Animal Research
Ethics (approval number: AREC-E-16-27-Hughes) and
signed, informed owner consent was obtained for all
patients included.
For the purpose of this study, 39 healthy female dogs,
presented for elective ovariohysterectomy at the UCD
Veterinary Hospital, were prospectively recruited. Both
privately owned dogs and shelter dogs were included in
the study. All were assigned an American Society of
Anesthesiologists (ASA) physical status grade 1. Patients
weighing less than 5 kg, paediatric (≤ 12 weeks) and geri-
atric patients (dogs in the last 25% of their predicted life
span) and patients assigned an ASA physical status grade
other than 1 were excluded.
Dogs were randomised with an online list randomizer
[19] to receive either midazolam (Hypnovel® 10 mgml-1,
Roche Products (UK) Ltd.; 0.25 mg kg-1) (group M) or
an equivalent volume of placebo (Hartmann’s Lactated
Ringer’s solution; B. Braun Melsungen AG, Germany;
0.125 ml kg-1) (group P) intravenously (IV) five minutes
prior to the commencement of surgical removal of the
first ovary.
Experimental protocol
Prior to any interaction with the patient, the primary
investigator observed the animal from a distance in the
kennel and assigned a cage demeanour score with
the help of a simple descriptive scale adapted from
Ferreira et al. (2015) (Table 1) [20]. A clinical exam-
ination and pre-anaesthetic assessment, but no blood
testing, was performed and an ASA physical status
grade was assigned to the patient.
Dogs were premedicated with acepromazine (Calmi-
vet® 5 mgml-1, Vetoquinol (France); 30 μg kg-1) and peth-
idine (Pethidine Hydrochloride 50 mgml-1, Mercury
Pharmaceuticals (Ireland) Ltd.; 3 mg kg-1) by intramus-
cular injection into the quadriceps muscle. A simple
descriptive sedation score (Table 2) [21] was assigned 20
min after premedication shortly followed by the place-
ment of an appropriately sized IV cannula in one of the
cephalic veins. A tight-fitting oxygen mask was then ap-
plied over the nose of the dog with an oxygen flow of 5
L min-1 supplied by the anaesthetic machine.
All dogs were anaesthetized by the main investigator,
who was unaware of the group allocation (midazolam or
placebo). Following IV cannula placement, anaesthesia
was induced with propofol (Vetofol, 10 mgml-1, Nor-
brook Laboratories (Ireland) Ltd.) IV to effect until jaw
tone was relaxed and endotracheal intubation was pos-
sible. The trachea of all dogs was intubated with a cuffed
endotracheal tube of appropriate size and animals were
connected to an anaesthetic machine via a circle breath-
ing system.
Anaesthesia was maintained with isoflurane (Iso-Vet
1000 mg g-1, Chanelle, Piramal Healthcare UK) vaporised
in oxygen with an oxygen flow set at 100 ml kg− 1 min− 1
for the first 15 min, and then reduced to 10ml kg-1
min-1. All dogs were allowed to breathe spontaneously
throughout the procedure. Intermittent positive pres-
sure ventilation was initiated only if end-tidal partial
pressure of carbon dioxide (PE’CO2) values exceeded
6.9 kPa or a period of apnoea with intermittent manu-
ally delivered breaths longer than five minutes
occurred.
For the duration of the anaesthetic, intravenous fluid
support was provided with Hartmann’s solution (Hart-
mann’s Lactated Ringer’s solution; B. Braun Melsungen
AG, Germany) at a rate of 10 ml kg-1 h-1.
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At the beginning of anaesthesia, the vaporizer was
initially set to achieve an end-tidal isoflurane concentra-
tion (FE’Iso) concentration of 1.1%. The dogs were
continuously monitored with a manual assessment of
muscle relaxation (jaw tone), eye position and palpebral
reflex, and a multiparameter monitor (B40; GE Health-
care, USA). The vaporizer setting was subsequently
adjusted to maintain or alter FE’Iso concentration
according to the depth of anaesthesia. If a dog showed
gross movement, an increase in jaw tone or a palpebral
reflex, a propofol bolus (1 mg kg-1) was administered IV
and FE’Iso was increased by 0.1–0.2%. If mean arterial
blood pressure (MAP) or heart rate (HR) increased or
decreased by more than 25% FE’Iso was also adjusted in
0.1% increments accordingly. If an FE’Iso above 1.6%
was required, additional analgesia was provided with
fentanyl (Sublimaze®, Janssen-Cilag Ltd., UK; 2 μg/kg)
intravenously (Fig. 1).
Monitored parameters were recorded every five mi-
nutes, starting at induction of anaesthesia, until the end
of anaesthesia, defined as discontinuation of isoflurane.
The parameters monitored included HR and electrocar-
diogram (ECG), respiratory rate (fR), PE’CO2 and FE’Iso,
haemoglobin oxygen saturation and arterial blood pres-
sure. During the preparation for surgery non-invasive
oscillometric blood pressure was measured. A 22G arter-
ial catheter was placed in the dorsal pedal artery and
intraoperatively invasive MAP was measured using a
pressure transducer zeroed to atmospheric pressure and
placed at the level of the heart.
Intra-operative analgesia was provided to all dogs by
the administration of morphine (Morphine Sulphate 10
mgml-1, Mercury Pharmaceuticals (Ireland) Ltd.; 0.3 mg
kg-1) slowly IV at the time of moving into the operating
room.
Ovariohysterectomy was performed by final year veter-
inary students under direct supervision of a qualified
veterinary surgeon. Once the first ovary was identified, the
treatment (midazolam / placebo) was administered and
the surgeons stopped all manipulation for five minutes to
allow sufficient time for the onset of action of midazolam.
Ovaries were removed using the triple clamp technique
and double ligation. The time of administration of mid-
azolam and the start and end of manipulation the ovaries
was recorded. Manipulation of the ovaries was defined as
stretching and tearing of the suspensory ligament, clamp-
ing and ligation of the ovarian pedicle, and removal of the
ovaries.
For the purpose of the study, bradycardia was defined
as HR below 80min-1, tachycardia as a HR above 120
min-1, normotension as a MAP between 70 and 120
mmHg, normocapnia as an PE’CO2 between 4.0 and 7.0
kPa, and normothermia as a temperature of 37.0–39.0 °
C. Bradycardic animals received either atropine (Atro-
pine sulfate; Mercury Pharmaceuticals Ltd., Ireland;
20 μg kg-1) or glycopyrrolate (Glycopyrronium Bromide;
Fig. 1 Flow chart for adjustment of anaesthetic depth in isoflurane anaesthetised healthy dogs undergoing ovariohysterectomy, adapted from
Enderle et al., 2008 [75]. End-tidal isoflurane concentration, FE’Iso
Kropf and Hughes Irish Veterinary Journal           (2018) 71:26 Page 3 of 10
Mercury Pharmaceuticals Ltd., Ireland; 5 μg kg-1) IV at
the anaesthetist’s discretion. Hypotension was treated
with a cascade of one to two boluses of crystalloid (Hart-
mann’s solution; 10 ml kg-1 over 15 min), followed by
one to four boluses of colloid (succinylated gelatin solu-
tion; Gelofusine® 40 mgml-1; B. Braun Melsungen AG,
Germany; 5 ml kg-1 over 15 min), dobutamine constant
rate infusion (CRI) (Dobutamine 12.5 mgml-1; Mercury
Pharmaceuticals Ltd., Ireland; 1–5 μg kg-1 min-1) and
noradrenaline CRI (Noradrenaline; Hospira Enterprises
B.V., The Netherlands; 0.1–1 μg kg-1 min-1). Apnoeic and
persistently hypercapneic (i.e. > 5 min) patients were
mechanically ventilated to achieve PE’CO2 values of 5.3
± 0.5 kPa. Active warming was provided with a forced
warm-air blanket (WarmTouch™ Patient Warming Sys-
tem, Nellcor (Medtronic), USA).
Following the end of surgery isoflurane was discontin-
ued, 100% oxygen (100ml kg-1 min-1) was administered
for 10 min or until extubation, the fluid rate was de-
creased to 2.5 ml kg-1 h-1 and meloxicam (Loxicom, 5
mgml-1, Norbrook Laboratories (Ireland) Ltd.; 0.2 mg
kg-1) was administered IV.
Animals were extubated when starting to swallow or at
the first sign of movement. During the recovery period oxy-
gen (5 Lmin-1) was provided by face mask. All hypothermic
animals were covered with an external heating device
(forced warm-air blanket) until rectal temperature reached
37 °C. Animals vocalizing and/or thrashing in recovery were
assessed for pain and dysphoria. Pain assessment was per-
formed with the short-form Glasgow Composite Measure
Pain Scale (CMPS-SF) [22]. To painful animals (CMPS-SF
score ≥ 5/20 or 6/24) rescue analgesia was provided with
morphine (0.2mg kg−1) IV over five minutes. If the animal
was not judged to be painful according to the CMPS-SF,
post-anaesthetic dysphoria was assumed and acepromazine
(2.5 μg kg-1) was administered IV.
A second dose of morphine (0.2 mg kg-1) was adminis-
tered postoperatively three to four hours following the
initial morphine dose and buprenorphine (Bupaq Multi-
dose 0.3 mgml-1 Injection for Dogs and Cats, Chanelle,
Ireland; 15 μg kg− 1 IV q8h) was administered subse-
quently every 6–8 h for 24 h.
Statistical analysis
Data analysis was performed using the statistical soft-
ware SPSS 24. A power analysis using data from a pilot
study, with eight dogs presented for ovariohysterectomy
to the UCD Veterinary Hospital, was carried out and re-
sults indicated that a minimum of 16 animals per group
was required to show a statistically significant difference
between groups for a change in blood pressure from
baseline of at least 25%. For the power analysis α was set
at 0.05 and β at 0.2 with a power of 0.8. Normality was
assessed using Shapiro-Wilk’s test and Normal Q-Q
Plots. Data for HR, MAP, FE’Iso, fR and PE’CO2 was par-
titioned into time periods (period 1: time in operating
room until start of surgery; period 2: start of surgery to
start of ovarian manipulation; period 3: manipulation of
the ovaries; period 4: manipulation of the uterus; and
period 5: abdominal closure) and mean values for each
time period were calculated for statistical analysis. For
HR and MAP, the percentage change from baseline (de-
fined as the mean HR and mean MAP during period 1)
was used for statistical analysis, rather than actual HR
and MAP, to allow for physiological differences in heart
rates and blood pressures between dogs of different
breeds and sizes as well as individual physiological
variability.
Differences in cage demeanour and sedation scores,
age, proportion of shelter-owned versus privately owned
dogs, weight, duration of anaesthesia, the length of the
Table 1 Cage dememeanour scoring system
Score Description
1 Severely anxious and aggressive, vocalizing, no body tremors
2 Anxious and vocalizing, no body tremors
3 Anxious but responsive to external stimuli
4 Calm and responsive to external stimuli
5 Excited, happy and responsive to external stimuli
Cage demeanour scoring system used to assess 39 healthy female dogs
admitted for elective ovariohysterectomy [20]
Table 2 Sedation scoring system
Score Description
1 Not very/not sedated:
Able to stand up and walk. Fully responsive. No signs of depression, drowsiness, ataxia or altered character with respect to how it was
without any medication
2 Slightly sedated:
Able to stand up and walk. Fully responsive but slow to react. Mild signs of depression, drowsiness, ataxia or mild changes in character
3 Sedated:
Able to stand up but reluctant to walk. Slow reaction to stimuli. Signs of depression, drowsiness, ataxia and changed character
4 Deeply/very sedated:
Unable to stand up and walk. Unresponsive to stimuli. Depressed, drowsy and sleepy
Sedation scoring system used to assess 39 healthy female dogs admitted for elective ovariohysterectomy, following pre-medication with pethidine (3 mg kg− 1)
and acepromazine (30 μg kg− 1) intramuscularly [21]
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time between administration of the treatment (midazo-
lam/placebo) and the end of anaesthesia, and the
amount of propofol required for anaesthetic induction
were investigated utilizing the Mann-Whitney U test,
the Kruskal-Wallis H test, the chi square test or the
independent-samples t-test as appropriate.
A two-way mixed ANOVA was used to examine varia-
tions in percentage change of HR from baseline, percent-
age change of MAP from baseline, PE'CO2, fR and FE'Iso.
The chi-square test of homogeneity, Fisher’s exact test,
the Mann-Whitney U test and the Kruskal-Wallis H test
were utilized as appropriate to assess group differences in
anaesthetic complications and the treatment of those
anaesthetic-related complications.
Results
For the purpose of the study, 39 female dogs were re-
cruited and randomly assigned to group P (20 dogs) or
group M (19 dogs). The statistical significance level was
set at α = 0.05 for all tests.
Breeds represented in our study were mixed breeds
(14), Siberian Husky (9), Labrador (5), Staffordshire Bull-
terrier (2), Jack Russell Terrier (2), Cocker Spaniel (1),
Samoyed (1), Shetland Sheepdog (1), Akita Inu (1), Golden
Retriever (1), and German Shepherd (1). Mixed breeds
(35.9%) and the Siberian Husky (23.1%) were overrepre-
sented in our study population. In group P 13 animals
were shelter-owned and 7 privately owned, in group M 11
animals were shelter-owned and 8 privately owned. No
differences in the proportion of shelter-owned versus pri-
vately owned animals could be observed between groups
and no differences in age, weight, cage demeanour or sed-
ation score were detected (Table 3). Length of anaesthesia,
the length of the time between administration of treat-
ment (midazolam/placebo) and end of anaesthesia, and
the amount of propofol required for anaesthetic induction
did not differ between groups (Table 3).
No statistically significant difference could be detected
between groups for changes in percentage change in HR
from baseline (p = 0.262) or percentage change in MAP
from baseline (p = 0.078) (Table 4). For both percentage
change in heart rate and blood pressure the main effect
of time showed statistically significant differences (p =
0.0005 and p = 0.0005, respectively) at different time pe-
riods. For heart rate, the percentage change was statisti-
cally significantly higher for time period 5, compared to
all other time periods. For the percentage change in
blood pressure, time period 1 (baseline) and 2 were sta-
tistically significantly lower, compared to time periods 3,
4 and 5. Time period 1 was statistically significantly
lower than time period 2. No statistical significant differ-
ence existed between time period 3 and 4, or between
time period 4 and 5. Time period 3 was statistically sig-
nificantly higher than time periods 1, 2 and 5. A statis-
tical significant difference (p = 0.004) was detected in
FE’Iso between group P and group M with group M re-
quiring a significantly less FE’Iso (14.3%) than group P
in the periods 3, 4, and 5, following the administration
of midazolam (Table 4).
Rescue analgesia was required intra-operatively in four
dogs: three dogs in group P and one dog in group M.
Post-operatively the dog from group M and one of the
dogs from group P required additional rescue analgesia.
Additionally, another dog from group P and three more
dogs from group M required rescue analgesia
post-operatively. Neither intra-operative (p = 0.605) nor
post-operative (p = 0.407) rescue analgesia requirements
displayed a statistically significant difference between
groups. Sedation for recovery due to dysphoria was re-
quired for two dogs in group M, but for no dog in group
P, with no statistical significance shown between groups
(p = 0.231).
Five dogs in group M and seven dogs in group P re-
quired mechanical ventilation. No statistical difference
in fR (p = 0.533), PE’CO2 (p = 0.067) or the need for
Table 3 Age, weight, cage demeanour and sedation scores, duration of anaesthesia, time from administration of midazolam/
placebo to end of anaesthesia, and amount of propofol administered for anaesthetic induction
Parameter Group P Group M
Age (months) 17 (6–48) 11 (6–54)
Weight (kg) 19.0 ± 6.5 18.6 ± 7.3
Cage demeanour score 5 (2–5) 5 (2–5)
Sedation score 3 (2–4) 3 (2–3)
Duration of anaesthesia (min) 158.6 ± 25.1 160.8 ± 26.8
Time from administration of M/P to end of GA (min) 92.2 ± 20.2 95.5 ± 18.6
Amount of propofol administered for anaesthetic induction (mg kg− 1) 3.65 (2.5–4.6) 3.6 (2.4–6.7)
Age, weight, cage demeanour score, sedation score, duration of anaesthesia, time from administration of M/P to end of anaesthesia, and amount of propofol
administered for anaesthetic induction in 39 healthy female dogs admitted for elective ovariohysterectomy. GA, general anaesthesia, M/P, Midazolam/Placebo.
Group M: midazolam (0.25 mg kg− 1), group P: Hartmann’s solution (0.125 ml − 1). Data presented as mean ± standard deviation or median (range) as appropriate
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mechanical ventilation (p = 0.731) was detected between
groups (Table 4).
Adverse events during anaesthesia included hypotension
(group P: 13 dogs; group M: 17 dogs), hypertension
(group P: four dogs; group M: two dogs), bradycardia
(group P: two dogs; group M: 1 dog), tachycardia (group
P: five dogs; group M: three dogs), apnoea (group P: two
dogs; group M: three dogs), hypercarbia (group P: five
dogs; group M: seven dogs) and hypothermia (group P:
three dogs; group M: five dogs). No statistically significant
difference in the incidence of complications in group M
and group P could be detected.
A large number of dogs required bolus fluid therapy,
due to intra-anaesthetic hypotension. Prior to treatment
with midazolam or placebo, dogs in group M required
statistically more bolus fluid therapy with succinylated
gelatine solution than dogs in group P (p = 0.012). How-
ever, no statistical difference was observed for crystalloid
fluid bolus pre-treatment, or with colloid or crystalloid
fluid bolus post study drug administration.
Three dogs in group M also received dobutamine CRI,
and, of those three dogs, two additionally received nor-
adrenaline CRI to treat hypotension. One dog in group
M and two dogs in group P received anticholinergics.
The dog in group M and one dog in group P were ad-
ministered glycopyrrolate. The other dog in group P re-
ceived atropine. No statistical significance could be
demonstrated for the use of dobutamine CRI, noradren-
aline CRI or anticholinergic agents.
Discussion
A significant reduction in isoflurane requirement was
detected in healthy dogs undergoing elective ovariohys-
terectomy after the administration of midazolam intra-
venously. However, the results of the presented study
show no significant changes in recorded cardiovascular
or respiratory parameters between group P and group M
during surgical removal of the ovaries.
Several studies have investigated the MAC-sparing ef-
fect of midazolam on volatile anaesthetics in humans
[23], goats [24, 25], and dogs [16, 26–28]. In 1988 Hall
et al. demonstrated an enflurane MAC-sparing effect of
midazolam CRI in dogs using the tail clamp technique.
Takeuchi et al. (1991) detected a ‘significant and propor-
tional decrease’ in the MAC of isoflurane, determined
via tail clamping, in dogs receiving a midazolam CRI.
Additionally, the study investigated the effect exerted by
midazolam CRI together with isoflurane (1 MAC) on
cardiovascular parameters during a period without any
stimulation and detected no differences with and with-
out midazolam. A study by Stegmann et al. exploring
the effect of midazolam premedication (0.1 mg kg-1) in
propofol-induced and isoflurane-maintained dogs under-
going ovariohysterectomy also found a reduction in re-
quirement of isoflurane with midazolam administration
[28]. In their study, the minimum isoflurane concentra-
tion required was determined by testing for a pedal
reflex. However, Seddighi et al. (2011), when studying
the influence of midazolam on the MAC of isoflurane in
Table 4 Heart rate, mean arterial blood pressure, respiratory rate, end-tidal carbon dioxide, and end-tidal isoflurane concentration
Para-meter Group Period 1 Period 2 Period 3 Period 4 Period 5
HR M 97.0 ± 12.3 104 ± 15.2 106 ± 11.9 105 ± 11.4 114 ± 15.9
P 101 ± 18.9 99 ± 14.2 105 ± 12.1 106 ± 14.5 119 ± 15.8
% change in HR from baseline (%) M N/A 9.3 ± 17.3 11.2 ± 17.8 9.9 ± 20.9 18.1 ± 23.4
P N/A −1.5 ± 12.6 4.7 ± 20.5 5.1 ± 27.0 19.6 ± 31.1
MAP (mmHg) M 63.0 ± 6.7 72.0 ± 11.0 89.3 ± 9.5 86.6 ± 10.6 82.1 ± 13.2
P 72.0 ± 10.1 81.1 ± 10.6 97.5 ± 12.5 90.8 ± 14.2 89.9 ± 10.7
% change in MAP from baseline (%) M N/A 11.0 ± 20.4 40.8 ± 18.4 39.0 ± 23.1 30.8 ± 23.9
P N/A 16.6 ± 17.2 38.2 ± 20.3 26.8 ± 19.8 27.9 ± 21.4
fR M 16.0 ± 6.5 17.1 ± 7.8 13.1 ± 5.3 13.1 ± 5.1 14.7 ± 5.8
P 19.0 ± 9.9 17.8 ± 10.8 17.5 ± 5.8 14.7 ± 6.0 15.3 ± 6.7
PE’CO2 (kPa) M 5.11 ± 0.41 5.42 ± 0.46 6.19 ± 0.56 5.88 ± 0.36 5.66 ± 0.51
P 5.35 ± 0.45 5.57 ± 0.56 5.91 ± 0.72 5.86 ± 0.7 5.76 ± 0.62
FE’Iso (%) M 1.03 ± 0.14 1.15 ± 0.11 1.2 ± 0.17* 1.22 ± 0.2* 1.23 ± 0.1*
P 1.05 ± 0.11 1.16 ± 0.11 1.35 ± 0.15 1.43 ± 0.16 1.42 ± 0.19
Difference FE’Iso (%) M/P 9.1 8.3 14.3 14.3 14.3
Mean values for heart rate (HR), mean arterial blood pressure (MAP), end-tidal isoflurane concentration (FE’Iso); respiratory rate (fR); and end-tidal carbon dioxide
(PE’CO2), and difference between groups in FE’Iso expressed in percent (% difference FE’Iso) for group P and group M for each time period (1–5). M/P, Midazolam/
Placebo; %, percentage; Group M: midazolam (0.25 mg kg− 1), group P: Hartmann’s solution (0.125 ml kg− 1). Period 1 (baseline): time in operating room until start
of surgery; Period 2: start of surgery to start of ovarian manipulation; Period 3: manipulation of the ovaries; Period 4: manipulation of the uterus; and Period 5:
abdominal closure. N/A, not applicable. Data presented as mean ± standard deviation. *Statistical significance (p < 0.05)
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dogs using electrical stimulation over the mid-ulnar
area, only observed a clinically significant MAC reduc-
tion at infusion rates of 10 μg kg− 1 min− 1 with a loading
dose of 0.8 mg kg− 1 [16]. At lower, clinically appropriate,
midazolam doses (0.2 mg/kg IV and 0.4 mg kg-1)
followed by a continuous rate infusion (CRI) of 2.5 μg/
kg/min and 5 μg kg-1 min− 1, respectively, a decrease in
MAC of isoflurane by only 11 ± 5% was observed [16].
In our study, a 14.3% decrease in isoflurane requirement
was detected after administration of midazolam in com-
parison to the placebo group. The authors considered
this to be a modest clinically significant difference in
end-tidal anaesthetic concentration.
Midazolam is mainly used for its anticonvulsant, seda-
tive and hypnotic, and muscle relaxant effects in veterin-
ary medicine [15]. An antinociceptive action is generally
not ascribed to systemic administration of midazolam in
dogs [16]. The effect of systemic administration of opi-
oids and benzodiazepines combined has been investi-
gated in rats [29], mice [30] and humans [31, 32]. A
positive analgesic effect was observed in human patients
after administration of flumazenil, a benzodiazepine an-
tagonist, in both patients that had been administered di-
azepam as part of the anaesthetic protocol as well as in
patients without prior benzodiazepine administration
[31, 32]. The negative analgesic interaction between opi-
oids and benzodiazepine agonists is thought to be caused
by a modulation of neuronal pathways via both GABAA
[31, 33] and NMDA receptor mechanisms [34, 35]. To
these authors’ knowledge the negative impact of benzodi-
azepines on postoperative opioid requirements has not
been investigated in a clinical veterinary setting, but in our
dogs no negative effect was observed.
Approximately 77% of our study population, irrespect-
ive of the group assignment, became hypotensive post--
induction of anaesthesia. Hypotension is a common
complication in human and veterinary anaesthesia [36, 37]
and is particularly prevalent between induction of anaes-
thesia and the beginning of surgery due to the influence of
anaesthetic drugs in a period of very little noxious stimu-
lation [36].
The phenothiazine acepromazine, a commonly used
sedative, causes a decrease in blood pressure at clinically
relevant doses [38]. Its vasodilatory action is mediated
via α1 adrenoceptor antagonism, depression of central
vasomotor centres and direct action on vascular smooth
muscle [39, 40]. Anaesthesia was induced with the
short-acting injectable anaesthetic propofol, which can
lead to hypotension through inhibition of the sympathetic
nervous system, impairment of baroreflex regulatory
mechanisms, and reduction in vascular tone through a
direct action on veins and arterioles [36, 41, 42]. Anaes-
thetic maintenance with volatile agents, such as isoflurane,
causes dose-dependent myocardial depression associated
with a decline in stroke volume as well as a decrease in
systemic vascular resistance, resulting in a reduction in ar-
terial blood pressure [43–45].
Opioids play a key role in the management of
peri-operative analgesia and sedation, often as a part of a
multimodal approach [46, 47]. The cardiovascular effects of
opioids at clinically relevant doses are generally minimal
[48, 49], although they can be associated with a centrally
mediated bradycardia [50]. With mild bradycardia, cardiac
output is maintained through an increase in stroke volume,
but more severe decreases in heart rate will result in a re-
duction in cardiac output [51]. Unfortunately, the combin-
ation with anaesthetic drugs, including benzodiazepines,
enhances the negative cardiovascular effects of opioids [52,
53]. Both morphine and pethidine are commonly used full
μ agonist opioid drugs, but pethidine, unlike morphine, is
unlikely to cause nausea and vomiting, when administered
as part of the premedication [54]. The opioid doses admin-
istered in our study protocol are at the lower end of recom-
mended dose ranges and we did not observe any negative
cardiovascular effects immediately associated with the ad-
ministration of the opioids themselves or when administer-
ing midazolam intra-operatively.
Our study was designed to investigate the effect of
midazolam, and all dogs received an otherwise uniform
anaesthetic protocol. It is therefore impossible to deduce
how much each individual drug administered, other than
midazolam, contributed to the overall observed
hypotension.
Final year veterinary students are required to perform
one elective ovariohysterectomy or castration under dir-
ect supervision by an experienced surgeon at our institu-
tion. Ovariohysterectomy performed by final year
students have been observed to take twice as long as
those performed by experienced surgeons [55–57]. This
held true for our study population, resulting not only in
a very long overall duration of anaesthesia, but also in a
particularly prolonged period inside the operating the-
atre without stimulation of the animal, while students
were getting ready to start the surgery.
Dogs in group M received significantly more colloid
fluid therapy in time periods 1 and 2 for the treatment
of hypotension, but this finding was not linked to group
difference in heart rate or blood pressure during the
same time periods. It can be speculated, that dogs allo-
cated to group M incidentally were more prone to
hypotension intra-operatively and required more fluid
bolus therapy to compensate for this fact. Independent
of this finding, the administration of midazolam did not
have a significant effect on blood pressure or heart rate
in the dogs studied here.
Blood pressure significantly increased with the start of
the manipulation of the ovaries in both groups and did
not significantly decrease during the following time
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periods. This is similar to findings in other studies [58,
59]. Traction on the suspensory ligament of each ovary
and ligation of the ovarian pedicle have been previously
identified as the most stimulating aspects of an ovario-
hysterectomy, as blood pressure increases significantly
during this phase and signs of inadequate depth of an-
aesthesia are often observed [60, 61]. Surprisingly, heart
rate was higher during the time period of abdominal
closure than during any other time period. Abdominal
wall closure appears to exert a major surgical stimulus.
The abdominal wall is richly innervated by branches of
the spinal nerves T7 – L3 and loco-regional anaesthesia in
the form of a transverse abdominis plane (TAP) block has
been shown to be an effective analgesic adjunct for
abdominal surgery in cats and dogs [62–64].
Dose-dependent respiratory depression, characterised
by an increase in arterial partial pressure of carbon diox-
ide, is an important side effect of many anaesthetic
drugs. Opioids elicit respiratory depression by acting on
μ and δ opioid receptors in medullary respiratory centres
and on μ opioid receptors at chemoreceptor sites [65].
Benzodiazepines act mainly on GABAA receptors. High
concentrations of GABAA receptors can be found in the
dorsal and ventral medullary groups and are thought to
have an important role in the control of ventilation [65].
Benzodiazepines and μ agonist opioids in combination
were shown to cause a more severe respiratory depres-
sion than either drug group alone in humans [66–68].
Despite extensive research the exact mechanism for the
potentiation of respiratory depression observed with the
combination of opioids and benzodiazepines remains
unascertained. Whether opioids and benzodiazepines
have simply an additive action, or if there is a more
complicated, most likely multifactorial interaction at play
involving pharmacokinetic or pharmacodynamic pro-
cesses, remains to be proven [68, 69]. However, at the
doses used in our study, no significant difference in
respiratory depression between the two groups was
evident.
No pre-anaesthetic haematological and serum bio-
chemistry testing was performed and we cannot fully ex-
clude the presence of underlying disease in the dogs
enrolled in the study. Hepatic or renal disease could
negatively affect the metabolism and elimination of mid-
azolam and other drugs. A delayed drug clearance would
be expected to result in a prolonged duration of action,
and possibly more severe drug effects, which was not
clinically observed. Moreover, studies in humans [70]
and dogs [71, 72] have detected little benefit of routine
pre-anaesthetic blood testing in young healthy individ-
uals unless history or physical examination results were
indicative of potential health problems.
While the number of dogs recruited for this study is
appropriate according to the performed power analysis,
it is a small sample size from a statistical point of view
and many of the observed adverse events occurred at a
very low frequency in our study population. The signifi-
cance of statistical results inferred from small frequency
events and/or small sample sizes should be critically
examined [73, 74] and future studies with larger sample
sizes would be desirable.
Due to the clinical nature of the study, inspired
isoflurane concentration was adjusted intra-operatively
to maintain an appropriate level of anaesthetic depth,
preventing any untoward effects of inadvertent anaes-
thetic overdose. This resulted in the above described and
discussed isoflurane-sparing effect observed with the ad-
ministration of midazolam. It is possible that, if the in-
spired isoflurane concentration had not been altered,
differences between groups in cardiovascular parameters
could have been detected.
Conclusion
In conclusion, a modest isoflurane-sparing effect
(14.3%), was observed with the administration of a single
bolus of midazolam in dogs prior to manipulation of the
ovaries during ovariohysterectomy in our clinical study
population. The findings of this study do not support
the use of midazolam to attenuate cardiovascular re-
sponses in dogs undergoing elective ovariohysterectomy.
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